Submitted by Anonymous (not verified) on 20 October 2026 - 15:52
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised